Regulation & Compliance

A new partnership tackles the exploding threat of non-human identities, aiming to govern the AI agents and bots now outnumbering humans in the enterprise.

A new survey shows 94% of IT leaders fear vendor lock-in, demanding practical AI and hybrid solutions over cloud-only hype. Is this the end of an era?

Amid rising demand, Sienna Senior Living expands its portfolio with key acquisitions in the GTA and Kelowna, consolidating its position in Canada's senior care sector.

Accord Healthcare's launch of generic lenalidomide signals a new era of affordability for a key cancer drug, intensifying competition and lowering costs.

The acquisition creates an end-to-end intelligence platform, combining institutional AI with alternative data to challenge generic models in finance.

A major patent deal shields Esperion's flagship drugs from generics, securing future revenue but delaying cheaper options for millions of patients.

A new collaborative is launching major health services, from maternal care to mental health, to address deep-seated disparities on Chicago's Far Southside.

Teamsters' national president and CA's Lt. Governor join striking CSU workers, accusing the university of unlawfully withholding contractually promised raises.

As deepfakes and synthetic identities surge, Aware, Inc. earns critical third-party certifications, proving its tech is secure, fair, and ready for reality.

Online casino Betty expands its Toronto footprint with new TFC and Argos partnerships, navigating a market defined by rapid growth and strict regulations.

Cyrano Therapeutics' CYR-064 shows promise in a Phase 2 study, potentially becoming the first approved drug for persistent post-viral smell loss.

Nakamoto Inc. acquires Bitcoin Magazine's parent and a key investment firm in an all-stock deal, raising questions about market influence and shareholder value.

A partial DHS shutdown deepens as Democrats demand major reforms to ICE operations, sparking a fierce debate over national security and civil liberties.

New research reveals a startling mobile security gap, with 72% of firms facing incidents and 65% losing customers as AI and speed pressures add new risks.

Lufax names Xiang Ji as its new CEO amid major financial struggles. The move signals a tighter grip from controlling shareholder Ping An Group.

A new network of local recycling facilities aims to solve the e-waste gap for small businesses, boosting data security and domestic materials recovery.

Neurotech leader BrainsWay adjusts its share structure in a move to enhance liquidity, clarify valuation, and attract a broader base of global investors.

NRx Pharmaceuticals gets a green light from the FDA to seek broader approval for its ketamine drug, NRX-100, using a novel real-world evidence approach.

As Xtract One readies its Q2 results, investors eye its booming backlog against a backdrop of rising competition and ethical questions in AI security.

With a massive dataset from $6.2B in prior authorizations, SamaCare's AI is speeding up access to critical drugs, but raises questions about market power.